Jean Paul Nicandro

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea‐predominant <scp>IBS</scp>

Filippo Cremonini, Jean Paul Nicandro, Victoria Atkinson et al. · Alimentary Pharmacology & Therapeutics · 2012 · 64 citations · Full text

A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program

Kenneth Tong, Jean Paul Nicandro, Reshma Shringarpure et al. · Therapeutic Advances in Gastroenterology · 2013 · 59 citations

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

Brian E. Lacy, Jean Paul Nicandro, Emil Chuang et al. · Therapeutic Advances in Gastroenterology · 2018 · 36 citations · Full text

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder

David A. Ginsberg, Marcus J. Drake, Albert Kaufmann et al. · The Journal of Urology · 2017 · 23 citations

Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS

Mark Tullman, Emmanuel Chartier‐Kastler, Alfred Kohan et al. · Neurology · 2018 · 22 citations · Full text